Fort Collins, CO, United States of America

Robert W Payne

This inventor holds 39 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Coherus Biosciences, Inc., E-Star Biotech, LLC, Other. Active years: 2000-2025.

USPTO Granted Patents = 39 (Patent Applications = 5)

% Patents Active = 51.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.9

ph-index = 19

Forward Citations = 662(Granted Patents)

Location History:

St. Petersburg, FL (US) (2000 - 2002)
Fort Collins, CO (US) (2016 - 2020)

Company Filing History:

35 out of 76

Coherus Biosciences, Inc.

3 out of 834,307

Other

patents

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Formulations

Adalimumab

Stable Aqueous Formulations

Syringe Design

Manufacturing Methods

Stability

Drug Delivery

Biologics

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427185 - Formulations of MANP and uses thereof (2025-09-30),

2. 10799585 - Stable aqueous formulations of adalimumab (2020-10-13),

3. 10786566 - Stable aqueous formulations of adalimumab (2020-09-29),

4. 10780163 - Stable aqueous formulations of adalimumab (2020-09-22),

5. 10772960 - Stable aqueous formulations of adalimumab (2020-09-15),

6. 10772959 - Stable aqueous formulations of adalimumab (2020-09-15),

7. 10722579 - Stable aqueous formulations of adalimumab (2020-07-28),

8. 10716854 - Stable aqueous formulations of adalimumab (2020-07-21),

9. 10716853 - Stable aqueous formulations of adalimumab (2020-07-21),

10. 10716852 - Stable aqueous formulations of adalimumab (2020-07-21),

11. 10688183 - Stable aqueous formulations of adalimumab (2020-06-23),

12. 10286072 - Methods of manufacturing stable aqueous formulations of adalimumab (2019-05-14),

13. 10286071 - Syringe containing stable aqueous formulations of adalimumab (2019-05-14),

14. 10207000 - Stable aqueous formulations of adalimumab (2019-02-19),

15. 10195275 - Stable aqueous formulations of adalimumab (2019-02-05),

Title: Innovator Spotlight: Robert W. Payne

Introduction: Robert W. Payne, based in Fort Collins, Colorado, is a notable inventor recognized for his contributions to pharmaceutical formulations. With an impressive portfolio of 35 patents, he has significantly impacted the field of biopharmaceuticals.

Latest Patents: Among his latest innovations are advanced formulations of adalimumab. These patents focus on stable aqueous pharmaceutical compositions that ensure the long-term storage of adalimumab. Payne's work outlines methods for manufacturing these compositions, as well as administration techniques and associated kits, showcasing his commitment to improving patient care through innovative solutions.

Career Highlights: Robert W. Payne currently works at Coherus Biosciences, Inc., where he continues to explore new avenues in biopharmaceuticals. His expertise in formulation science has been pivotal in the development of stable drug products that enhance the efficacy and safety of treatments for various diseases.

Collaborations: In his professional journey, Payne collaborates with Mark Cornell Manning, another distinguished innovator in the field. Their partnership exemplifies the collaborative spirit that drives innovation in the biopharmaceutical sector, allowing for the sharing of knowledge and expertise to tackle complex challenges.

Conclusion: Robert W. Payne's dedication to advancing pharmaceutical innovations through his patents and collaborative efforts positions him as a leading figure in the field of biopharmaceuticals. His work not only exemplifies the importance of patenting inventive solutions but also highlights the significant impacts these innovations can have on healthcare outcomes.